EHS
EHS

STAT Plus: PhRMA asks the U.S. trade rep to place added pressure on four countries over patent and pricing policies



As drug makers increasingly grapple with other countries over the cost of medicines, the pharmaceutical industry’s trade group is asking the Trump administration to take “urgent action” against two dozen countries over their pricing policies and for engaging in “unfair” practices that threaten intellectual property rights.

In comments filed with the U.S. trade representative, the trade group also made a point of singling out Japan, South Korea, Malaysia, and Canada for various moves that will purportedly cost drug makers large amounts of sales and jeopardize their ability to develop innovative medicines.

Continue to STAT Plus to read the full story…

Source link

EHS
Back to top button